WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011

Jan 6, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-01-04

Reporting Person: Hunt Jeffrey C (VP Pharma Pckg Systems)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$	2020-07-06	Common Stock (12610.0000)		Direct

Footnotes

F1: This grant vest in four annual installments beginning on the first anniversary of the grant date.

F2: Conversion or Exercise Price of Derivative Security is $36.29